Trial Profile
A single center, retrospective study evaluated efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Mar 2016 New trial record